RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+36.79%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$724M
AUM Growth
+$724M
(+18%)
Cap. Flow
-$65.6M
Cap. Flow
% of AUM
-9.05%
Top 10 Holdings %
Top 10 Hldgs %
67.17%
Holding
36
New
9
Increased
7
Reduced
9
Closed
3
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$42.5M |
| 2 |
Prothena Corp
PRTA
|
$23.2M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$21.1M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$16.9M |
| 5 |
TherapeuticsMD
TXMD
|
$15.4M |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$123M |
| 2 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$33M |
| 3 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$21M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$19.4M |
| 5 |
Omeros
OMER
|
$18.5M |
Sector Composition
| 1 | Healthcare | 84.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DYAX
1
DELISTED
DYAX CORPORATION
DYAX
| $71.5M | 7.46% | 10,418,379 -490,000 | -4% | -$3.36M |
|
2
Novavax
NVAX
$1.21B
| $65.5M | 6.84% | 20,800,000 +3,629,199 | +21% | +$11.4M |
|
|
3
Acadia Pharmaceuticals
ACAD
$4.38B
| $55.9M | 5.84% | 2,035,510 -4,494,300 | -69% | -$123M |
|
|
4
TherapeuticsMD
TXMD
$12.8M
| $48.4M | 5.05% | 16,528,641 +5,266,033 | +47% | +$15.4M |
|
5
Insmed
INSM
$28.8B
| $46.6M | 4.86% | 2,983,319 +550,000 | +23% | +$8.59M |
|
6
Sangamo Therapeutics
SGMO
$157M
| $44.7M | 4.66% | 4,258,244 -1,109,850 | -21% | -$11.6M |
|
|
ACHN
7
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $43.7M | 4.56% | 14,457,061 +7,001,859 | +94% | +$21.1M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $42.5M | 4.44% | +5,844,700 | New | +$42.5M |
|
|
LUMO
9
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $34.6M | 3.61% | 1,840,294 | – | – |
|
|
10
Prothena Corp
PRTA
$441M
| $33.3M | 3.48% | 1,646,399 +1,148,592 | +231% | +$23.2M |
|
11
Xoma
XOMA
$392M
| $31.1M | 3.24% | 6,915,525 +216,967 | +3% | +$974K |
|
|
DSCI
12
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $24.7M | 2.58% | 1,994,876 | – | – |
|
|
VIRX
13
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $24.2M | 2.52% | 4,869,261 +152,965 | +3% | +$759K |
|
|
KERX
14
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $24.1M | 2.52% | 2,391,261 -3,268,024 | -58% | -$33M |
|
|
HPTX
15
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $23.6M | 2.46% | 902,858 | – | – |
|
|
CCXI
16
DELISTED
ChemoCentryx, Inc.
CCXI
| $16.9M | 1.77% | +3,045,380 | New | +$16.9M |
|
|
BLUE
17
DELISTED
bluebird bio
BLUE
| $12.6M | 1.32% | +467,418 | New | +$12.6M |
|
18
Myriad Genetics
MYGN
$593M
| $10.6M | 1.1% | +450,000 | New | +$10.6M |
|
|
19
Omeros
OMER
$283M
| $10.3M | 1.07% | 1,055,311 -1,897,693 | -64% | -$18.5M |
|
|
AMPE
20
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $9.94M | 1.04% | +1,325,566 | New | +$9.94M |
|
|
ENZ
21
DELISTED
Enzo Biochem, Inc.
ENZ
| $8.44M | 0.88% | 3,348,029 | – | – |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.36M | 0.87% | +551,723 | New | +$8.36M |
|
23
Dynavax Technologies
DVAX
$1.19B
| $7.14M | 0.75% | 6,000,000 | – | – |
|
24
Achieve Life Sciences
ACHV
$152M
| $7.08M | 0.74% | 763,332 -100,000 | -12% | -$927K |
|
25
PTC Therapeutics
PTCT
$3.92B
| $6.44M | 0.67% | +300,000 | New | +$6.44M |
|